Literature DB >> 7043712

Naproxen and diflunisal in osteoarthrosis.

P M Brooks, M A Dougan, D Thomas, L J Hills, P J Smith.   

Abstract

Sixty-two patients with osteoarthrosis entered a 10-week double-blind cross-over trial of diflunisal and naproxen. Eight patients withdrew for drug-related reason, and seven for other reasons. There was no statistically significant difference in parameters of disease activity on each treatment period, but naproxen produced fewer withdrawals due to drug-related side-effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043712     DOI: 10.1093/rheumatology/21.2.95

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN: 0300-3396


  2 in total

1.  Clinical trials: proposal for an international coding system (ICS).

Authors:  N Bellamy
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

2.  A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis.

Authors:  M J Franssen; F W Gribnau; L B van de Putte
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.